HOME >> MEDICINE >> NEWS
The Wistar Institute licenses rubella vaccine seed stock to Microgen of Russia

The Wistar Institute announced today that it has licensed the seed stock for its rubella vaccine to Microgen of Russia for a modest fee in the interest of promoting global public health. The Vishnevskaya-Rostropovich Foundation, headed by renowned cellist Maestro Mstislav Rostropovich, facilitated communication between the organizations in support of the agreement.

Developed in the 1960s at Wistar, the rubella vaccine has eradicated the disease in the U.S., according to a statement by the Centers for Disease Control and Prevention made in March 2005.

In the Russian Federation and the Newly Independent States (N.I.S.), however, rubella remains a serious problem. The rubella vaccine has not been widely accessible in these countries.

"We are pleased to make available the seed stock of our rubella vaccine to the Russian Federation and the N.I.S.," says Russel E. Kaufman, M.D., president and CEO of The Wistar Institute. "Eradicating rubella is a significant global public health priority, and The Wistar Institute is eager to ensure that the benefits of this vaccine are available to people worldwide."

Congenital rubella syndrome (CRS) is an important cause of severe birth defects. When a woman is infected with the rubella vaccine early in pregnancy, she has a 90 percent chance of passing the virus on to her fetus. The virus can kill the fetus or cause CRS. Although CRS can be a relatively mild disease in children, in fetuses it causes deafness, blindness, mental retardation, and other birth defects.

Scientists at The Wistar Institute began work on the vaccine after a pandemic of rubella swept across Europe and the U.S. in 1963 and 1964, leaving in its wake about 12,000 infants born deaf or deaf and blind. Their rubella vaccine was introduced for use by physicians in 1969, signaling the beginning of the end for the virus in the U.S.

The Vishnevskaya-Rostropovich Foundation encouraged the agreement between Wistar an
'"/>

Contact: Franklin Hoke
hoke@wistar.org
215-898-3716
The Wistar Institute
5-Jan-2006


Page: 1 2

Related medicine news :

1. Wistar emeritus professor Stanley A. Plotkin, M.D., elected to Institute of Medicine
2. 2005 Wistar Institute Science Journalism award winner announced
3. Worcester Polytechnic Institute to host national forum on locating first responders inside buildings
4. Wesley Research Institute study targets pharmacists to help diabetes sufferers
5. CIRM awards $3.79 million to Burnham Institute
6. Institute of Medicine Advisory: Public health physicians
7. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
8. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
9. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
10. Dr. Eli Peli of Schepens Eye Research Institute elected SPIE fellow
11. AGA Institute takes leadership role in exploring obesity and its complications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to ... unique items from across the nation, this holiday-themed event will raise funds and awareness ... VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... WESTWOOD, Mass. , Oct. 4, 2017  According to the Centers ... by the end of October . PhysicianOne Urgent Care is helping communities ... Westchester, NY , by offering no-cost* flu shots through ... , as mandated by certain health insurance regulations. ... The best time to get a flu shot is by ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
Breaking Medicine Technology:
Cached News: